The purpose of this study is to determine whether BVS(Bioresorbable Vascular Scaffold) implantation with optimal medical therapy can improve the outcome of patients with variant angina and moderate coronary artery disease.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
bioresorbable vascular scaffold implantation plus optimal medical treatment
Asan Medical Center
Seoul, South Korea
Composite of all cause death, myocardial infarction, and angina-related hospitalization
Time frame: 2year
Variant angina
by Ergonovine test
Time frame: 2year
All cause death
Time frame: 2year
Cardiac death
Time frame: 2year
Repeat revascularization
Time frame: 2year
Scaffold thrombosis
Time frame: 2year
Myocardial infarction
Time frame: 2year
Stroke
Time frame: 2year
Angina-related hospitalization
Time frame: 2year
Composite event of death or myocardial infarction
Time frame: 2year
Composite event of cardiac death or myocardial infarction
Time frame: 2year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.